Abstract

Happy 2010 to all our readers, and welcome to a new Neuro-Oncology. After months of previews and updates, you now hold in your hands the first issue of the journal published by Oxford Journals and the first published on a monthly schedule. First, a little about our new partner. Oxford Journals is a division of Oxford University Press, which is a department of Oxford University and which has been publishing since 1478—more than half a millennium. The Journals division, which was established just over a century ago, publishes more than 200 academic and research journals covering a broad range of subject areas, two-thirds of which are, like Neuro-Oncology, published in collaboration with learned societies or other international organizations. One of the things we particularly like about our new partner is that its stated mission—to bring the highest quality research to the widest possible audience—is very much in keeping with the journal's and the Society for Neuro-Oncology's. We are looking forward to capitalizing on Oxford's truly global reach, which means more than simply selling publications on a worldwide basis—the Press has offices not only at its home base in the United Kingdom but also throughout Asia, Africa, Europe, Australia, and North and South America. Our new partner promises to provide Neuro-Oncology's authors with an excellent level of service, including a move away from traditional transfer of copyright to the granting of licenses that allow the research to be as widely disseminated as possible. Oxford Journals is also one of the first publishers to experiment with open access in publishing through its Oxford Open initiative. This option allows authors to, for a modest fee, make their articles immediately available to the scientific community at no charge, which helps ensure that important results are read (and cited) as soon as possible. The Press' developing countries initiatives, whereby institutions in traditionally underserved nations are granted access to publications at either deeply discounted prices or even free, are another vital aspect of our new affiliation and are very much in keeping with the Society's international outreach goals. We are also happy to report that authors and reviewers will not have to learn a new system for online submission and reviewing of manuscripts, or even be bothered with obtaining new passwords and so on; Editorial Manager, the web-based submission and tracking system we've used for the last several years, is fully supported by Oxford. The journal website, on the other hand, does have a new home: http://neuro-oncology.oxfordjournals.org. While you are there, don't forget to sign up for electronic Table of Contents and Advance Access alerts, so that you can access each new issue of the journal online as soon as it is posted. If you have been receiving alerts from Duke University Press, you will need to register again due to data protection regulations.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.